Bell Bank’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,241
| Closed | -$256K | – | 181 |
|
|
2024
Q2 | $256K | Sell |
1,241
-260
| -17% | -$53.7K | 0.02% | 172 |
|
|
2024
Q1 | $407K | Sell |
1,501
-215
| -13% | -$58.3K | 0.04% | 150 |
|
|
2023
Q4 | $406K | Sell |
1,716
-146
| -8% | -$34.5K | 0.04% | 141 |
|
|
2023
Q3 | $365K | Sell |
1,862
-81
| -4% | -$15.9K | 0.04% | 146 |
|
|
2023
Q2 | $409K | Sell |
1,943
-82
| -4% | -$17.2K | 0.04% | 141 |
|
|
2023
Q1 | $409K | Sell |
2,025
-87
| -4% | -$17.6K | 0.04% | 139 |
|
|
2022
Q4 | $460K | Sell |
2,112
-26
| -1% | -$5.67K | 0.05% | 135 |
|
|
2022
Q3 | $421K | Sell |
2,138
-40
| -2% | -$7.88K | 0.05% | 133 |
|
|
2022
Q2 | $466K | Buy |
2,178
+171
| +9% | +$36.6K | 0.06% | 137 |
|
|
2022
Q1 | $570K | Buy |
+2,007
| New | +$570K | 0.06% | 119 |
|